These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

732 related items for PubMed ID: 11989561

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Improved management of abdominal undescended testicular tumors with bulky confluent retroperitoneal nodal metastases.
    Kulkarni JN, Desai SM, Phadke GK, Tongaonkar HB.
    J Urol; 1996 Oct; 156(4):1341-4. PubMed ID: 8808867
    [Abstract] [Full Text] [Related]

  • 7. Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors.
    Böhlen D, Borner M, Sonntag RW, Fey MF, Studer UE.
    J Urol; 1999 Apr; 161(4):1148-52. PubMed ID: 10081858
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The stage I yolk sac tumor of testis in children younger than 2 years, chemotherapy or not?
    Liu HC, Liang DC, Chen SH, Liu FL, Chang PY, Sheu JC, Wang NL.
    Pediatr Hematol Oncol; 1998 Apr; 15(3):223-8. PubMed ID: 9615319
    [Abstract] [Full Text] [Related]

  • 11. Results of postchemotherapy adjunctive retroperitoneal lymph node dissection in non-seminomatous germ cell cancer patients.
    Goepel M, Recker F, Otto T, Krege S, Rübben H.
    Urol Int; 1996 Apr; 57(4):209-12. PubMed ID: 8961487
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Surgery for testicular cancer: indication, results and technical aspects.
    Khouni H, Ghozzi S, Ramzi K, Smaali CH, Majed H, Ben Rais N.
    Tunis Med; 2005 Dec; 83 Suppl 12():78-83. PubMed ID: 16430075
    [Abstract] [Full Text] [Related]

  • 15. Early resection of residual tumor during cisplatin, vinblastine, bleomycin combination chemotherapy in stage III and bulky stage II nonseminomatous testicular cancer.
    Pizzocaro G, Salvioni R, Pasi M, Zanoni F, Milani A, Pilotti S, Monfardini S.
    Cancer; 1985 Jul 15; 56(2):249-55. PubMed ID: 2408728
    [Abstract] [Full Text] [Related]

  • 16. Resection of postchemotherapy residual masses and limited retroperitoneal lymphadenectomy in patients with metastatic testicular nonseminomatous germ cell tumors.
    Aprikian AG, Herr HW, Bajorin DF, Bosl GJ.
    Cancer; 1994 Aug 15; 74(4):1329-34. PubMed ID: 8055456
    [Abstract] [Full Text] [Related]

  • 17. Post-chemotherapy retroperitoneal teratoma in nonseminomatous germ cell tumors: Do predictive factors exist? Results from a national multicenter study.
    Dusaud M, Malavaud B, Bayoud Y, Sebe P, Hoepffner JL, Salomon L, Houlgatte A, Pignot G, Rigaud J, Fléchon A, Pfister C, Rouprêt M, Soulié M, Méjean A, Durand X.
    J Surg Oncol; 2016 Dec 15; 114(8):992-996. PubMed ID: 27859263
    [Abstract] [Full Text] [Related]

  • 18. Management of germ cell testicular cancer with pulmonary metastases.
    Schnorrer M, Ondrus D, Cársky S, Hornák M, Belan V, Kausitz J, Matośka J.
    Neoplasma; 1996 Dec 15; 43(1):47-50. PubMed ID: 8843960
    [Abstract] [Full Text] [Related]

  • 19. Risk-adapted treatment for patients with clinical stage I nonseminomatous germ cell tumor of the testis.
    Amato RJ, Ro JY, Ayala AG, Swanson DA.
    Urology; 2004 Jan 15; 63(1):144-8; discussion 148-9. PubMed ID: 14751368
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.